Skip to Content
Radiation Research Program
Contact NExT
Show menu
Search this site
Last Updated: 03/10/23

Selected RRP Staff Publications

Selected RRP publications 2017 to present:

Radiation-Induced Pulmonary Fibrosis: Roles of Therapy-Induced Senescence and microRNAs
Prasanna PGS, Aryankalayil M, Citrin DE, Coleman CN. Int J Radiat Biol. 2023 Feb 10:1-16. doi: 10.1080/09553002.2023.2177768. Epub ahead of print. PMID: 36763093.

The United States department of energy and national institutes of health collaboration: medical care advances via discovery in physical sciences
Keppel C, Weisenberger A, Atanasijevic Contractor T, Wang S, Zubal G, Buchsbaum J, Brechbiel Emeritus M, Capala J, Escorcia F, Obcemea C, Boehnlein A, Heyes G, Bourne P, Cherry S, Colby E, El Fakhri G, Gillo J, Gropler R, Gueye P, Tourassi G, Peggs S, Woody C. Med Phys. 2023 Jan 27. doi: 10.1002/mp.16252. Epub ahead of print. PMID: 36705550.

Understanding the challenges of delivering radiotherapy in low- and middle-income countries in Africa
Ige T, Lewis P, Shelley C, Pistenmaa D, Coleman CN, Aggarwal A, Dosanjh M; Survey respondents and authors. J Cancer Policy. 2022 Dec 10;35:100372. doi: 10.1016/j.jcpo.2022.100372. Epub ahead of print. PMID: 36512899.

The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation
Hong JA, Vikram B, Buchsbaum J, Capala J, Livinski A, Teicher B, Prasanna P, Ahmed MM, Obcemea C, Coleman CN, Graham Espey M. Radiat Res. 2022 Dec 1;198(6):625-631. doi: 10.1667/RADE-22-00077.1. PMID: 35976726; PMCID: PMC9817232.

Inter-agency perspective: Translating advances in biomarker discovery and medical countermeasures development between terrestrial and space radiation environments
DiCarlo AL, Carnell LS, Rios CI, Prasanna PG. Life Sci Space Res (Amst). 2022 Nov;35:9-19. doi: 10.1016/j.lssr.2022.06.004. Epub 2022 Jun 14. PMID: 36336375; PMCID: PMC9832585.

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321)
Dunkel IJ, Piao J, Chantada GL, Banerjee A, Abouelnaga S, Buchsbaum JC, Merchant TE, Granger MM, Jubran RF, Weinstein JL, Saguilig L, Abramson DH, Krailo MD, Rodriguez-Galindo C, Chintagumpala MM. J Clin Oncol. 2022 Nov 20;40(33):3839-3847. doi: 10.1200/JCO.21.02337. Epub 2022 Jul 12. PMID: 35820112; PMCID: PMC9671757.

The NCI Glioblastoma Therapeutics Network (GTN)
Forry S, Hubbard L, Espey MG, Vikram B, Mann B, Tawab-Amiri A, Hecht T. Neuro Oncol. 2022 Nov 11:noac247. doi: 10.1093/neuonc/noac247. Epub ahead of print. PMID: 36366801.

Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation
Chopra S, Shankavaram U, Bylicky M, Dalo J, Scott K, Aryankalayil MJ, Coleman CN. Sci Rep. 2022 Nov 19;12(1):19941. doi: 10.1038/s41598-022-24051-6. PMID: 36402833; PMCID: PMC9675751.

Radiation disasters - long term consequences: reflections and summary of a recent symposium
Burtt JJ, Akiba S, Bazyka D, Coleman CN, Hatch M, Bernstein JL. Int J Radiat Biol. 2022 Sep 26:1-8. doi: 10.1080/09553002.2022.2110315. Epub ahead of print. PMID: 36154906.

Serum RNA biomarkers for predicting survival in non-human primates following thoracic radiation
May JM, Shankavaram U, Bylicky MA, Chopra S, Scott K, Martello S, Thrall K, Axtelle J, Menon N, Coleman CN, Aryankalayil MJ. Sci Rep. 2022 Jul 19;12(1):12333. doi: 10.1038/s41598-022-16316-x. PMID: 35853961; PMCID: PMC9296457.

Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio
Buchsbaum JC, Espey MG, Obcemea C, Capala J, Ahmed M, Prasanna PG, Vikram B, Hong JA, Teicher B, Aryankalayil MJ, Bylicky MA, Coleman CN. J Clin Oncol. 2022 Jun 10;40(17):1861-1869. doi: 10.1200/JCO.21.02579. Epub 2022 Mar 4. PMID: 35245101; PMCID: PMC9177246.

A roadmap to clinical trials for FLASH
Taylor PA, Moran JM, Jaffray DA, Buchsbaum JC. Med Phys. 2022 Jun;49(6):4099-4108. doi: 10.1002/mp.15623. Epub 2022 Apr 25. PMID: 35366339; PMCID: PMC9321729.

Low-dose radiotherapy for COVID-19 pneumonia and cancer: summary of a recent symposium and future perspectives
Little MP, Zhang W, van Dusen R, Hamada N, Bugden M, Cao M, Thomas K, Li D, Wang Y, Chandrashekhar M, Khan MK, Coleman CN. Int J Radiat Biol. 2023;99(2):357-371. doi: 10.1080/09553002.2022.2074165. Epub 2022 May 26. PMID: 35511152.

Predictive Radiation Oncology - A New NCI-DOE Scientific Space and Community
Buchsbaum JC, Jaffray DA, Ba D, Borkon LL, Chalk C, Chung C, Coleman MA, Coleman CN, Diehn M, Droegemeier KK, Enderling H, Espey MG, Greenspan EJ, Hartshorn CM, Hoang T, Hsiao HT, Keppel C, Moore NW, Prior F, Stahlberg EA, Tourassi G, Willcox KE. Radiat Res. 2022 Apr 1;197(4):434-445. doi: 10.1667/RADE-22-00012.1. PMID: 35090025; PMCID: PMC9058979.

Long-term expression changes of immune-related genes in prostate cancer after radiotherapy
Eke I, Aryankalayil MJ, Bylicky MA, Sandfort V, Vanpouille-Box C, Nandagopal S, Graves EE, Giaccia AJ, Coleman CN. Cancer Immunol Immunother. 2022 Apr;71(4):839-850. doi: 10.1007/s00262-021-03036-w. Epub 2021 Aug 25. PMID: 34435232; PMCID: PMC8873240.

Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner
Eke I, Aryankalayil MJ, Bylicky MA, Makinde AY, Liotta L, Calvert V, Petricoin EF, Graves EE, Coleman CN. Sci Rep. 2022 Mar 3;12(1):3500. doi: 10.1038/s41598-022-07394-y. PMID: 35241721; PMCID: PMC8894377.

Joint NIBIB/NCI/SNMMI Workshop on Directly Imaging Targeted Radionuclide Therapy Isotopes
Zubal IG, Capala J. J Nucl Med. 2022 Feb;63(2):23N-25N. PMID: 35101930.

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
Schoenfeld JD, Giobbie-Hurder A, Ranasinghe S, Kao KZ, Lako A, Tsuji J, Liu Y, Brennick RC, Gentzler RD, Lee C, Hubbard J, Arnold SM, Abbruzzese JL, Jabbour SK, Uboha NV, Stephans KL, Johnson JM, Park H, Villaruz LC, Sharon E, Streicher H, Ahmed MM, Lyon H, Cibuskis C, Lennon N, Jhaveri A, Yang L, Altreuter J, Gunasti L, Weirather JL, Mak RH, Awad MM, Rodig SJ, Chen HX, Wu CJ, Monjazeb AM, Hodi FS. Lancet Oncol. 2022 Feb;23(2):279-291. doi: 10.1016/S1470-2045(21)00658-6. Epub 2022 Jan 13. PMID: 35033226; PMCID: PMC8813905.

Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE. J Nucl Med. 2021 Dec;62(Suppl 3):3S-11S. doi: 10.2967/jnumed.121.262749. PMID: 34857621.

Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice
Pandit-Taskar N, Iravani A, Lee D, Jacene H, Pryma D, Hope T, Saboury B, Capala J, Wahl RL. J Nucl Med. 2021 Dec;62(Suppl 3):60S-72S. doi: 10.2967/jnumed.121.262977. PMID: 34857623.

National Cancer Institute support for targeted alpha-emitter therapy
Hong JA, Brechbiel M, Buchsbaum J, Canaria CA, Coleman CN, Escorcia FE, Espey M, Kunos C, Lin F, Narayanan D, Capala J. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):64-72. doi: 10.1007/s00259-021-05503-z. Epub 2021 Aug 11. PMID: 34378064.

Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
Wahl RL, Sgouros G, Iravani A, Jacene H, Pryma D, Saboury B, Capala J, Graves SA. J Nucl Med. 2021 Dec;62(Suppl 3):23S-35S. doi: 10.2967/jnumed.121.262751. PMID: 34857619.

Overview and Lessons From the Preclinical Chemoradiotherapy Testing Consortium
Buchsbaum JC, Coleman CN, Bernhard EJ, Espey MG, Vikram B. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1126-1130. doi: 10.1016/j.ijrobp.2021.07.1709. Epub 2021 Aug 1. PMID: 34348172.

United States medical preparedness for nuclear and radiological emergencies
DiCarlo AL, Homer MJ, Coleman CN. J Radiol Prot. 2021 Dec 6;41(4):10.1088/1361-6498/ac0d3f. doi: 10.1088/1361-6498/ac0d3f. PMID: 34153947; PMCID: PMC8648948.

Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Monjazeb AM, Giobbie-Hurder A, Lako A, Thrash EM, Brennick RC, Kao KZ, Manuszak C, Gentzler RD, Tesfaye A, Jabbour SK, Alese OB, Rahma OE, Cleary JM, Sharon E, Mamon HJ, Cho M, Streicher H, Chen HX, Ahmed MM, Mariño-Enríquez A, Kim-Schulze S, Gnjatic S, Maverakis E, Marusina AI, Merleev AA, Severgnini M, Pfaff KL, Lindsay J, Weirather JL, Ranasinghe S, Spektor A, Rodig SJ, Hodi FS, Schoenfeld JD. Clin Cancer Res. 2021 Sep 1;27(17):4940. doi: 10.1158/1078-0432.CCR-21-2698. Erratum for: Clin Cancer Res. 2021 May 1;27(9):2470-2480. PMID: 34470811.

Overview of the First NRG Oncology-National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy
Roncali E, Capala J, Benedict SH, Akabani G, Bednarz B, Bhadrasain V, Bolch WE, Buchsbaum JC, Coleman NC, Dewaraja YK, Frey E, Ghaly M, Grudzinski J, Hobbs RF, Howell RW, Humm JL, Kunos CA, Larson S, Lin FI, Madsen M, Mirzadeh S, Morse D, Pryma D, Sgouros G, St James S, Wahl RL, Xiao Y, Zanzonico P, Zukotynski K. J Nucl Med. 2021 Aug 1;62(8):1133-1139. doi: 10.2967/jnumed.120.255547. Epub 2020 Dec 4. PMID: 33277396; PMCID: PMC8833877.

Whole blood gene expression within days after total-body irradiation predicts long term survival in Gottingen minipigs
Chopra S, Moroni M, Sanjak J, MacMillan L, Hritzo B, Martello S, Bylicky M, May J, Coleman CN, Aryankalayil MJ. Sci Rep. 2021 Aug 5;11(1):15873. doi: 10.1038/s41598-021-95120-5. PMID: 34354115; PMCID: PMC8342483.

Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model
Aryankalayil MJ, Martello S, Bylicky MA, Chopra S, May JM, Shankardass A, MacMillan L, Sun L, Sanjak J, Vanpouille-Box C, Eke I, Coleman CN. J Transl Med. 2021 Aug 7;19(1):336. doi: 10.1186/s12967-021-02998-w. PMID: 34364390; PMCID: PMC8349067.

FLASH Radiation Therapy: New Technology Plus Biology Required
Buchsbaum JC, Coleman CN, Espey MG, Prasanna PGS, Capala J, Ahmed MM, Hong JA, Obcemea C. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1248-1249. doi: 10.1016/j.ijrobp.2021.01.053. Epub 2021 Feb 3. PMID: 33548337.

Multispecialty Enterprise Imaging Workgroup Consensus on Interactive Multimedia Reporting Current State and Road to the Future: HIMSS-SIIM Collaborative White Paper
Roth CJ, Clunie DA, Vining DJ, Berkowitz SJ, Berlin A, Bissonnette JP, Clark SD, Cornish TC, Eid M, Gaskin CM, Goel AK, Jacobs GC, Kwan D, Luviano DM, McBee MP, Miller K, Hafiz AM, Obcemea C, Parwani AV, Rotemberg V, Silver EL, Storm ES, Tcheng JE, Thullner KS, Folio LR. J Digit Imaging. 2021 Jun;34(3):495-522. doi: 10.1007/s10278-021-00450-5. Epub 2021 Jun 15. PMID: 34131793; PMCID: PMC8329131.

Comments on "Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma" by Toussaint, et al.: Prior Similar Field Arrangement Work and a Need for Variable RBE Use
Buchsbaum JC. Radiother Oncol. 2021 May;158:327-329. doi: 10.1016/j.radonc.2020.11.035. Epub 2021 Feb 4. PMID: 33548283.

Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care
Coleman CN, Buchsbaum JC, Prasanna PGS, Capala J, Obcemea C, Espey MG, Ahmed MM, Hong JA, Vikram B. JNCI Cancer Spectr. 2021 May 17;5(4):pkab046. doi: 10.1093/jncics/pkab046. PMID: 34350377; PMCID: PMC8328099.

Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors
Patel S, Vogel J, Bradley K, Chuba PJ, Buchsbaum J, Krasin MJ. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28253. doi: 10.1002/pbc.28253. PMID: 33818883.

Toward Individualized Voxel-Level Dosimetry for Radiopharmaceutical Therapy
Xiao Y, Roncali E, Hobbs R, James SS, Bednarz B, Benedict S, Dewaraja YK, Frey E, Grudzinski J, Sgouros G, Buchsbaum JC, Capala J. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):902-904. doi: 10.1016/j.ijrobp.2020.08.026. PMID: 33610302.

Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls
Venkatesulu BP, Lester S, Hsieh CE, Verma V, Sharon E, Ahmed M, Krishnan S. JNCI Cancer Spectr. 2020 Nov 19;5(1):pkaa103. doi: 10.1093/jncics/pkaa103. PMID: 33437924; PMCID: PMC7717342.

Long and short non-coding RNA and radiation response: a review.
May JM, Bylicky M, Chopra S, Coleman CN, Aryankalayil MJ. Transl Res. 2021 Jul;233:162-179. doi: 10.1016/j.trsl.2021.02.005. Epub 2021 Feb 11. PMID: 33582242.

Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment.
Ige TA, Jenkins A, Burt G, Angal-Kalinin D, McIntosh P, Coleman CN, Pistenmaa DA, O'Brien D, Dosanjh M. Clin Oncol (R Coll Radiol). 2021 Jun 8:S0936-6555(21)00185-0. doi: 10.1016/j.clon.2021.05.008. Epub ahead of print. PMID: 34116903.

Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies.
Jabbour SK, Williams TM, Sayan M, Miller ED, Ajani JA, Chang AC, Coleman N, El-Rifai W, Haddock M, Ilson D, Jamorabo D, Kunos C, Lin S, Liu G, Prasanna PG, Rustgi AK, Wong R, Vikram B, Ahmed MM. J Natl Cancer Inst. 2021 Jun 1;113(6):665-679. doi: 10.1093/jnci/djaa195. PMID: 33351071.

SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme.
Cerna D, Lim B, Adelabu Y, Yoo S, Carter D, Fahim A, Mitsuuchi Y, Teicher BA, Bernhard E, Coleman CN, Takebe N, Ahmed MM. Radiat Res. 2021 Jun 1;195(6):549-560. doi: 10.1667/RADE-20-00171.1. PMID: 33826739.

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
Monjazeb AM, Giobbie-Hurder A, Lako A, Thrash EM, Brennick RC, Kao KZ, Manuszak C, Gentzler RD, Tesfaye A, Jabbour SK, Alese OB, Rahma OE, Cleary JM, Sharon E, Mamon HJ, Cho M, Streicher H, Chen HX, Ahmed MM, Mariño-Enríquez A, Kim-Schulze S, Gnjatic S, Maverakis E, Marusina AI, Merleev AA, Severgnini M, Pfaff KL, Lindsay J, Weirather JL, Ranasinghe S, Spektor A, Rodig SJ, Hodi SF, Schoenfeld JD. Clin Cancer Res. 2021 May 1;27(9):2470-2480. doi: 10.1158/1078-0432.CCR-20-4632. Epub 2021 Feb 10. PMID: 33568343; PMCID: PMC8102320.

NCI support for pediatric radiation therapy: Past, present, and future.
Buchsbaum JC, Vikram B. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28689. doi: 10.1002/pbc.28689. Epub 2020 Sep 17. PMID: 32939959.

Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Demaria S, Guha C, Schoenfeld J, Morris Z, Monjazeb A, Sikora A, Crittenden M, Shiao S, Khleif S, Gupta S, Formenti SC, Vikram B, Coleman CN, Ahmed MM. J Immunother Cancer. 2021 Apr;9(4):e002038. doi: 10.1136/jitc-2020-002038. PMID: 33827904; PMCID: PMC8031689.

Therapy-Induced Senescence: Opportunities to Improve Anti-Cancer Therapy.
Prasanna PG, Citrin DE, Hildesheim J, Ahmed MM, Venkatachalam S, Riscuta G, Xi D, Zheng G, van Deursen J, Goronzy J, Kron SJ, Anscher MS, Sharpless NE, Campisi J, Brown SL, Niedernhofer LJ, O'Loghlen A, Georgakilas AG, Paris F, Gius D, Gewirtz DA, Schmitt CA, Abazeed ME, Kirkland JL, Richmond A, Romesser PB, Lowe SW, Gil J, Mendonca MS, Burma S, Zhou D, Coleman CN. J Natl Cancer Inst. 2021 Apr 1:djab064. doi: 10.1093/jnci/djab064. Epub ahead of print. PMID: 33792717.

In Reply to Breneman et al.
Buchsbaum JC, Coleman CN, Capala J, Obcemea C. Int J Radiat Oncol Biol Phys. 2021 Mar 26:S0360-3016(21)00293-5. doi: 10.1016/j.ijrobp.2021.03.033. Epub ahead of print. PMID: 33781844.

Current Status of Radiopharmaceutical Therapy.
St James S, Bednarz B, Benedict S, Buchsbaum JC, Dewaraja Y, Frey E, Hobbs R, Grudzinski J, Roncali E, Sgouros G, Capala J, Xiao Y. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):891-901. doi: 10.1016/j.ijrobp.2020.08.035. Epub 2020 Aug 14. PMID: 32805300.

Voxel-Level Dosimetry for Radiopharmaceutical Therapy.
Xiao Y, Roncali E, Hobbs R, James SS, Bednarz B, Benedict S, Dewaraja YK, Frey E, Grudzinski J, Sgouros G, Buchsbaum JC, Capala J. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):902-904. doi: 10.1016/j.ijrobp.2020.08.026. PMID: 33610302.

Radiopharmaceutical Validation for Clinical Use.
Kunos CA, Howells R, Chauhan A, Myint ZW, Bernard ME, El Khouli R, Capala J. Front Oncol. 2021 Mar 3;11:630827. doi: 10.3389/fonc.2021.630827. PMID: 33747951; PMCID: PMC7966985.

Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
Prasanna PG, Rawojc K, Guha C, Buchsbaum JC, Miszczyk JU, Coleman CN. Int J Radiat Oncol Biol Phys. 2021 Feb 25:S0360-3016(21)00224-8. doi: 10.1016/j.ijrobp.2021.02.043. Epub ahead of print. PMID: 33640423.

The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy.
Eke I, Bylicky MA, Sandfort V, Chopra S, Martello S, Graves EE, Coleman CN, Aryankalayil MJ. Mol Ther Nucleic Acids. 2021 Feb 24;24:175-187. doi: 10.1016/j.omtn.2021.02.024. PMID: 33767914; PMCID: PMC7960506.

FLASH Radiotherapy: New Technology Plus Biology Required.
Buchsbaum JC, Coleman CN, Espey MG, Prasanna PGS, Capala J, Ahmed MM, Hong JA, Obcemea C. Int J Radiat Oncol Biol Phys. 2021 Feb 3:S0360-3016(21)00130-9. doi: 10.1016/j.ijrobp.2021.01.053. Epub ahead of print. PMID: 33548337.

National Cancer Institute Workshop on Artificial Intelligence in Radiation Oncology: Training the Next Generation.
Kang J, Thompson RF, Aneja S, Lehman C, Trister A, Zou J, Obcemea C, El Naqa I. Pract Radiat Oncol. 2021 Jan-Feb;11(1):74-83. doi: 10.1016/j.prro.2020.06.001. Epub 2020 Jun 13. PMID: 32544635; PMCID: PMC7293478.

A New Generation of "Magic Bullets" for Molecular Targeting of Cancer.
Capala J, Kunos CA. Clin Cancer Res. 2021 Jan 15;27(2):377-379. doi: 10.1158/1078-0432.CCR-20-3690. Epub 2020 Nov 3. PMID: 33144340.

Radiopharmaceutical Delivery for Theranostics: Pharmacokinetics and Pharmacodynamics.
Sunderland JJ, Ponto LB, Capala J. Semin Radiat Oncol. 2021 Jan;31(1):12-19. doi: 10.1016/j.semradonc.2020.07.009. PMID: 33246631.

Capturing Acquired Wisdom, Enabling Healthful Aging, and Building Multinational Partnerships Through Senior Global Health Mentorship.
Coleman CN, Wong JE, Wendling E, Gospodarowicz M, O'Brien D, Ige TA, Aruah SC, Pistenmaa DA, Amaldi U, Balogun OO, Brereton HD, Formenti S, Schroeder K, Chao N, Grover S, Hahn SM, Metz J, Roth L, Dosanjh M. Glob Health Sci Pract. 2020 Dec 23;8(4):626-637. doi: 10.9745/GHSP-D-20-00108. PMID: 33361231; PMCID: PMC7784062.

Achieving flexible competence: bridging the investment dichotomy between infectious diseases and cancer.
Coleman CN, Mansoura MK, Marinissen MJ, Grover S, Dosanjh M, Brereton HD, Roth L, Wendling E, Pistenmaa DA, O'Brien DM. BMJ Glob Health. 2020 Dec;5(12):e003252. doi: 10.1136/bmjgh-2020-003252. PMID: 33303514; PMCID: PMC7733114.

Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT).
Roncali E, Capala J, Benedict SH, Akabani G, Bednarz B, Bhadrasain V, Bolch WE, Buchsbaum J, Clarke BN, Coleman N, Dewaraja YK, Frey EC, Ghaly M, Grudzinski J, Hobbs RF, Howell RW, Humm JL, Kunos C, Larson SM, Lin FI, Madsen MT, Mirzadeh S, Morse DL, Pryma DA, Sgouros G, St James S, Wahl RL, Xiao Y, Zanzonico PB, Zukotynski K. J Nucl Med. 2020 Dec 4:jnumed.120.255547. doi: 10.2967/jnumed.120.255547. Epub ahead of print. PMID: 33277396.

Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group.
Zhang H, Wu X, Zhang X, Chang SX, Megooni A, Donnelly ED, Ahmed MM, Griffin RJ, Welsh JS, Simone CB 2nd, Mayr NA. Radiat Res. 2020 Dec 1;194(6):665-677. doi: 10.1667/RADE-20-00047.1. PMID: 33348375.

Radiation-induced Adaptive Response: New Potential for Cancer Treatment.
Coleman CN, Eke I, Makinde AY, Chopra S, Demaria S, Formenti SC, Martello S, Bylicky M, Mitchell JB, Aryankalayil MJ. Clin Cancer Res. 2020 Nov 15;26(22):5781-5790. doi: 10.1158/1078-0432.CCR-20-0572. Epub 2020 Jun 17. PMID: 32554542; PMCID: PMC7669567.

Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Prasanna PG, Woloschak GE, DiCarlo AL, Buchsbaum JC, Schaue D, Chakravarti A, Cucinotta FA, Formenti SC, Guha C, Hu DJ, Khan MK, Kirsch DG, Krishnan S, Leitner WW, Marples B, McBride W, Mehta MP, Rafii S, Sharon E, Sullivan JM, Weichselbaum RR, Ahmed MM, Vikram B, Coleman CN, Held KD. Radiat Res. 2020 Nov 10;194(5):452-464. doi: 10.1667/RADE-20-00211.1. PMID: 33045077; PMCID: PMC8009137.

Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report.
Hua CH, Vern-Gross TZ, Hess CB, Olch AJ, Alaei P, Sathiaseelan V, Deng J, Ulin K, Laurie F, Gopalakrishnan M, Esiashvili N, Wolden SL, Krasin MJ, Merchant TE, Donaldson SS, FitzGerald TJ, Constine LS, Hodgson DC, Haas-Kogan DA, Mahajan A, Laack NN, Marcus KJ, Taylor PA, Ahern VA, Followill DS, Buchsbaum JC, Breneman JC, Kalapurakal JA. Pediatr Blood Cancer. 2020 Oct;67(10):e28629. doi: 10.1002/pbc.28629. Epub 2020 Aug 9. PMID: 32776500; PMCID: PMC7774502.

Gene Expression Profiles from Heart, Lung and Liver Samples of Total-Body-Irradiated Minipigs: Implications for Predicting Radiation-Induced Tissue Toxicity.
Chopra S, Moroni M, Martello S, Bylicky M, May J, Hritzo B, MacMillan L, Coleman CN, Aryankalayil MJ. Radiat Res. 2020 Oct 2;194(4):411-430. doi: 10.1667/RADE-20-00123.1. PMID: 32936898.

Radiopharmaceutical Switch Maintenance for Relapsed Ovarian Carcinoma.
Kunos CA, Capala J. Pharmaceuticals (Basel). 2020 Sep 30;13(10):287. doi: 10.3390/ph13100287. PMID: 33008086; PMCID: PMC7600139.

Overcoming Challenges in Providing Radiation Therapy to Patients With Cancer in Nigeria and Experience in the National Hospital Abuja, Nigeria.
Aruah SC, Asogwa OC, Ubah FI, Maurice NN, Oyesegun R, Ige TA, Coleman CN, Dosanjh M, Pistenmaa D. JCO Glob Oncol. 2020 Aug;6:1232-1236. doi: 10.1200/JGO.19.00177. PMID: 32755480; PMCID: PMC7456314.

Phase 0 Radiopharmaceutical-Agent Clinical Development.
Kunos CA, Rubinstein LV, Capala J, McDonald MA. Front Oncol. 2020 Aug 18;10:1310. doi: 10.3389/fonc.2020.01310. PMID: 33014772; PMCID: PMC7461940.

Memorial Tribute to Eli Glatstein.
Chabner BA, Coleman N, Kaufman D, Lister A, Rengan R. Oncologist. 2020 Jul;25(7):638-640. doi: 10.1634/theoncologist.2020-0498. Epub 2020 Jun 5. PMID: 32501581; PMCID: PMC7356754.

Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy.
Griffin RJ, Ahmed MM, Amendola B, Belyakov O, Bentzen SM, Butterworth KT, Chang S, Coleman CN, Djonov V, Formenti SC, Glatstein E, Guha C, Kalnicki S, Le QT, Loo BW Jr, Mahadevan A, Massaccesi M, Maxim PG, Mohiuddin M, Mohiuddin M, Mayr NA, Obcemea C, Petersson K, Regine W, Roach M, Romanelli P, Simone CB 2nd, Snider JW, Spitz DR, Vikram B, Vozenin MC, Abdel-Wahab M, Welsh J, Wu X, Limoli CL. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):766-778. doi: 10.1016/j.ijrobp.2020.03.028. Epub 2020 Apr 13. PMID: 32298811.

Examining geographic accessibility to radiotherapy in Canada and Greenland for indigenous populations: Measuring inequities to inform solutions.
Chan J, Friborg J, Zubizarreta E, van Eck JW, Hanna TP, Bourque JM, Gaudet M, Dennis K, Olson R, Coleman CN, Petersen AJ, Grau C, Abdel-Wahab M, Brundage M, Slotman B, Polo A. Radiother Oncol. 2020 May;146:1-8. doi: 10.1016/j.radonc.2020.01.023. Epub 2020 Feb 14. PMID: 32065874.

Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting.
Suneja G, Mattes MD, Mailhot Vega RB, Escorcia FE, Lawton C, Greenberger J, Kesarwala AH, Spektor A, Vikram B, Deville C, Siker M. Adv Radiat Oncol. 2020 May 21;5(5):798-803. doi: 10.1016/j.adro.2020.05.003. PMID: 33083641; PMCID: PMC7557133.

Development of Novel Radiosensitizers through the National Cancer Institute's Small Business Innovation Research Program.
Zakeri K, Narayanan D, Prasanna PGS, Vikram B, Buchsbaum JC. Radiat Res. 2020 May;193(5):425-434. doi: 10.1667/RR15545.1. Epub 2020 Mar 27. PMID: 32216707; PMCID: PMC7266046.

Eli J. Glatstein: A Steward Extraordinaire of Radiation Oncology.
Coleman CN, Hoppe RT, Metz JM. Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):1-5. doi: 10.1016/j.ijrobp.2020.01.016. PMID: 32277912.

Eli J. Glatstein: Inspiring and Provoking Critical Thinking.
Coleman CN, Mitchell JB, Hahn SM, McKenna WG. Radiat Res. 2020 Apr;193(4):318-321. doi: 10.1667/RR00EG.1. Epub 2020 Jan 30. PMID: 31999506.

Novel Radiation Therapy Paradigms and Immunomodulation: Heresies and Hope.
Dutt S, Ahmed MM, Loo BW Jr, Strober S. Semin Radiat Oncol. 2020 Apr;30(2):194-200. doi: 10.1016/j.semradonc.2019.12.006. PMID: 32381299; PMCID: PMC7213065.

Sixteenth Annual Warren K. Sinclair Keynote Address: Frontiers in Medical Radiation Science.
Coleman CN. Health Phys. 2020 Apr;118(4):349-353. doi: 10.1097/HP.0000000000001240. PMID: 32039927.

Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?
Prasanna PGS, Narayanan D, Zhang K, Rahbar A, Coleman CN, Vikram B. Radiat Res. 2020 Mar;193(3):199-208. doi: 10.1667/RR15553.1. Epub 2020 Jan 7. PMID: 31910120.

53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy.
Eke I, Zong D, Aryankalayil MJ, Sandfort V, Bylicky MA, Rath BH, Graves EE, Nussenzweig A, Coleman CN. Nucleic Acids Res. 2020 Feb 20;48(3):1314-1326. doi: 10.1093/nar/gkz1139. PMID: 31822909; PMCID: PMC7026586.

Implementation of New Biology-Based Radiation Therapy Technology: When Is It Ready So "Perfect Makes Practice?".
Coleman CN, Ahmed MM. Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):934-937. doi: 10.1016/j.ijrobp.2019.08.013. PMID: 31748143.

Clinical Outcome Assessments Toolbox for Radiopharmaceuticals.
Kunos CA, Capala J, Dicker AP, Movsas B, Ivy SP, Minasian LM. Front Oncol. 2019 Oct 10;9:1028. doi: 10.3389/fonc.2019.01028. PMID: 31649885; PMCID: PMC6795707.

A Broad Impact for Global Oncology.
Coleman CN, Wendling EN, Pistenmaa DA. JAMA Oncol. 2019 Oct 1;5(10):1397-1398. doi: 10.1001/jamaoncol.2019.2387. PMID: 31393528.

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM. Cancer Res. 2019 Sep 1;79(17):4326-4330. doi: 10.1158/0008-5472.CAN-19-0803. Erratum in: Cancer Res. 2019 Nov 15;79(22):5897. PMID: 31481419.

Enhancing Career Paths for Tomorrow's Radiation Oncologists.
Vapiwala N, Thomas CR Jr, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD Jr, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):52-63. doi: 10.1016/j.ijrobp.2019.05.025. Epub 2019 May 22. PMID: 31128144; PMCID: PMC7084166.

Monte Carlo Processing on a Chip (MCoaC)-preliminary experiments toward the realization of optimal-hardware for TOPAS/Geant4 to drive discovery.
Abhyankar YS, Dev S, Sarun OS, Saxena A, Joshi R, Darbari H, Sajish C, Sonavane UB, Gavane V, Deshpande A, Dixit T, Harsh R, Badwe R, Rath GK, Laskar S, Faddegon B, Perl J, Paganetti H, Schuemann J, Srivastava A, Obcemea C, Nath AK, Sharma A, Buchsbaum J. Phys Med. 2019 Aug;64:166-173. doi: 10.1016/j.ejmp.2019.06.016. Epub 2019 Jul 16. PMID: 31515016; PMCID: PMC7238758.

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer.
George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM. 2019 Aug 15;125(16):2732-2746. doi: 10.1002/cncr.32150. Epub 2019 Apr 24. PMID: 31017664; PMCID: PMC6663584.

Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences.
Yock AD, Mohan R, Flampouri S, Bosch W, Taylor PA, Gladstone D, Kim S, Sohn J, Wallace R, Xiao Y, Buchsbaum J. Pract Radiat Oncol. 2019 Jul-Aug;9(4):200-207. doi: 10.1016/j.prro.2018.12.002. Epub 2018 Dec 15. PMID: 30562614; PMCID: PMC6571070.

Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master Files.
Kunos CA, Capala J, Ivy SP. Front Oncol. 2019 Jun 28;9:573. doi: 10.3389/fonc.2019.00573. PMID: 31316916; PMCID: PMC6611355.

NCTN Assessment on Current Applications of Radiomics in Oncology.
Nie K, Al-Hallaq H, Li XA, Benedict SH, Sohn JW, Moran JM, Fan Y, Huang M, Knopp MV, Michalski JM, Monroe J, Obcemea C, Tsien CI, Solberg T, Wu J, Xia P, Xiao Y, El Naqa I. Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):302-315. doi: 10.1016/j.ijrobp.2019.01.087. Epub 2019 Jan 31. PMID: 30711529; PMCID: PMC6499656.

Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer.
Kunos CA, Capala J, Kohn EC, Ivy SP. Front Oncol. 2019 Jun 26;9:560. doi: 10.3389/fonc.2019.00560. PMID: 31297338; PMCID: PMC6607970.

Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers.
Kunos CA, Capala J, Finnigan S, Smith GL, Ivy SP. Front Oncol. 2019 Mar 26;9:180. doi: 10.3389/fonc.2019.00180. PMID: 30984615; PMCID: PMC6448015.

Radiopharmaceuticals for Relapsed or Refractory Leukemias.
Kunos CA, Capala J, Ivy SP. Front Oncol. 2019 Feb 25;9:97. doi: 10.3389/fonc.2019.00097. PMID: 30859091; PMCID: PMC6397856.

Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
Satpathy M, Wang L, Zielinski RJ, Qian W, Wang YA, Mohs AM, Kairdolf BA, Ji X, Capala J, Lipowska M, Nie S, Mao H, Yang L. Theranostics. 2019 Jan 24;9(3):778-795. doi: 10.7150/thno.29964. PMID: 30809308; PMCID: PMC6376473.

Advancing Targeted Radionuclide Therapy Through the National Cancer Institute's Small Business Innovation Research Pathway.
Zakeri K, Narayanan D, Evans G, Prasanna P, Buchsbaum JC, Vikram B, Capala J. J Nucl Med. 2019 Jan;60(1):41-49. doi: 10.2967/jnumed.118.214684. Epub 2018 Jul 20. PMID: 30030338; PMCID: PMC6910624.

Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.
Kaveh Zakeri, MD, Deepa Narayanan, MS, Bhadrasain Vikram, MD, Greg Evans, PhD, C. Norman Coleman, MD, Pataje G.S. Prasanna, PhD. International Journal of Radiation Oncology, January 2019.

Medical countermeasures for radiation induced health effects: report of an Interagency Panel Session held at the NASA Human Research Program Investigator's Workshop, 26 January 2017.
Lisa S. Carnell, Mary Homer, Keith Hoots, Heather Meeks, Pataje G. S. Prasanna, Carmen Rios, Lisa C. Simonsen, Lanyn P. Taliaferro & Lynne K. Wathen. International Journal of Radiation Biology, September 2019. ISSN: 0955-3002.s

Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico.
Kelly C. Falls, Ricky A. Sharma, Yaacov R. Lawrence, Richard A. Amos, Sunil J. Advani, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Pataje G. Prasanna. Radiation Research, 190, 350-360 (2018) 0033-7587/18.

Robustness analysis for external beam radiotherapy treatment plans: describing uncertainty scenarios and reporting their dosimetric consequences.
Adam D. Yock PhD, Radhe Mohan PhD, Stella Flampouri PhD, Walter Bosch DSc, Paige Taylor MS, David Gladstone ScD, Siyong Kim PhD, Jason Sohn PhD, Robert Wallace PhD, Ying Xiao PhD, Jeff Buchsbaum MD, PhD. Practical Radiation Oncology. 2018. ISSN 1879-8500

The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.
Robert H. Press, Hui-Kuo G. Shu, Hyunsuk Shim, James M. Mountz, Brenda F. Kurland, Richard L. Wahl, Ella F. Jones, Nola M. Hylton, Elizabeth R. Gerstner, Robert J. Nordstrom, Lori Henderson, Karen A. Kurdziel, Bhadrasain Vikram, Michael A. Jacobs, Matthias Holdhoff, Edward Taylor, David A. Jaffray, Lawrence H. Schwartz, David A. Mankoff, Paul E. Kinahan, Hannah M. Linden, Philippe Lambin, Thomas J. Dilling, Daniel L. Rubin, Lubomir Hadjiiski, John M. Buatti. International Journal of Radiation Oncology, Biology, Physics. (in press 2018)

Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.
Aryankalayil MJ, Chopra S, Makinde A, Eke I, Levin J, Shankavaram U, MacMillan L, Vanpouille-Box C, Demaria S, Coleman CN. Biomarkers. 2018 May 25:1-26. PMID: 29799276

Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't!
Zakeri K, Coleman CN, Vikram B. Front Oncol. 2018 Apr 30;8:130. Review. PMID: 29761073

The Future of Radiobiology.
Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ. J Natl Cancer Inst. 2018 Apr 1;110(4):329-340. PMID: 29126306

Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms?
Miszczyk J, Rawojć K, Panek A, Borkowska A, Prasanna PGS, Ahmed MM, Swakoń J, Gałaś A. Clin Transl Radiat Oncol. 2018 Jan 31;9:23-29. doi: 10.1016/j.ctro.2018.01.004. eCollection 2018 Feb. PMID:29594247

Accurate, Precision Radiation Medicine: A Meta-Strategy for Impacting Cancer Care, Global Health, and Nuclear Policy and Mitigating Radiation Injury From Necessary Medical Use, Space Exploration, and Potential Terrorism.
Coleman CN, Prasanna PGS, Bernhard EJ, Buchsbaum JC, Ahmed MM, Capala J, Obcemea C, Deye JA, Pistenmma DA, Vikram B, Bernier J, Dosanjh M., Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):250-253. PMID: 29726348

The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 2: American Indian patients.
McClelland S 3rd, Leberknight J, Guadagnolo BA, Coleman CN, Petereit DG. Adv Radiat Oncol. 2017 Aug 26;3(1):3-7. PMID: 29556572

Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine.
Kunos CA, Coleman CN. Int J Radiat Oncol Biol Phys. 2018 Jan 8. pii: S0360-3016(17)30644-2. PMID: 29325810

Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.
Aryankalayil MJ, Chopra S, Levin J, Eke I, Makinde A, Das S, Shankavaram U, Vanpouille-Box C, Demaria S, Coleman CN. Radiat Res. 2018 Mar;189(3):251-263. PMID: 29309266

Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example.
Eke I, Makinde AY, Aryankalayil MJ, Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin EF, Brown MF, Stommel JM, Ahmed MM, Coleman CN. Mol Cancer Ther. 2018 Feb;17(2):355-367. PMID: 28802252

Radiation-Induced Large Vessel Cerebral Vasculopathy in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.
Kralik SF, Watson GA, Shih CS, Ho CY, Finke W, Buchsbaum J. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):817-824. PMID: 28867358

Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.
Kunos CA, Galanis E, Buchsbaum J, Shi Q, Strauss LC, Coleman CN, Ahmed MM. J Neurooncol. 2017 Sep;134(3):551-557. Review. PMID: 28560665

Implementing Cancer Care for the Undeserved Globally: From the "5 R's" of Radiobiology to the "7 P's" of Global Cancer Care.
Williams TR, Coleman CN. Semin Radiat Oncol. 2017 Apr;27(2):95-97. PMID: 28325247

Cancer Care Access and Outcomes for American Indian Populations in the United States: Challenges and Models for Progress.
Guadagnolo BA, Petereit DG, Coleman CN. Semin Radiat Oncol. 2017 Apr;27(2):143-149. Review. PMID: 28325240

Global Health in Radiation Oncology: The Emergence of a New Career Pathway.
Rodin D, Yap ML, Grover S, Longo JM, Balogun O, Turner S, Eriksen JG, Coleman CN, Giuliani M. Semin Radiat Oncol. 2017 Apr;27(2):118-123. Review. PMID: 28325237

Mobilising Expertise and Resources to Close the Radiotherapy Gap in Cancer Care.
Rodin D, Longo J, Sherertz T, Shah MM, Balagun O, Wendling N, Van Dyk J, Coleman CN, Xu MJ, Grover S. Clin Oncol (R Coll Radiol). 2017 Feb;29(2):135-140. PMID: 27955997